Please fill in a valid value for all required fields
Please ensure all values are in a proper format.
Are you sure you want to leave this form and resume later?
Are you sure you want to leave this form and resume later? If so, please enter a password below to securely save your form.
Save and Resume Later
Save and get link
You must upload one of the following file types for the selected field:
There was an error displaying the form. Please copy and paste the embed code again.
Apply Discount
You saved
with code
Submit Form
Submitting
Validating
There was an error initializing the payment processor on this form. Please contact the form owner to correct this issue.
Please check the field:
Fields
Pre Test
1. Isolated post-capillary pulmonary arterial hypertension is defined hemodynamically as ______________.
*
A. Mean arterial pressure of >10 mmHg, pulmonary capillary wedge pressure >25 mmHg, and a pulmonary vascular resistance <2 Woods Units
B. Mean arterial pressure of >10 mmHg, pulmonary capillary wedge pressure >25 mmHg, and a pulmonary vascular resistance <3 Woods Units
C. Mean arterial pressure of >20 mmHg, pulmonary capillary wedge pressure >15 mmHg, and a pulmonary vascular resistance <3 Woods Units
D. Mean arterial pressure of >15 mmHg, pulmonary capillary wedge pressure >10 mmHg, and a pulmonary vascular resistance <2Woods Units
2. According to the 6th World Symposium on Pulmonary Hypertension, combined pre- and post-capillary pulmonary hypertension is classified as ________________________.
*
A. Group 1 and 2
B. Group 1 and 5
C. Group 2 and 4
D. Group 2 and 5
3. Chronic thromboembolic pulmonary hypertension (CTEPH) may be cured with ________________________.
*
A. Pulmonary thromboendarterectomy (PTE)
B. Riociguat
C. Phosphodiesterase 5 inhibitors
D. Transcatheter aortic valve replacement (TAVR)
4. Which of the following is not a common side effect associated with soluble guanylate cyclase stimulators (sGC)?
*
A. Headache
B. Dizziness
C. Dyspepsia/gastritis
D. Nosebleeds
5. A 45-year-old patient with a known history of pulmonary hypertension secondary to valvular heart disease has recently moved to your area. She is a WHO functional class 4, with frequently repeated syncope, a Peak VO2 of 7 ml/min/kg, an NT-proBNP of 1470 ng/l, and a right atrial pressure of 16 mmHg. What would be the best management option for this patient?
*
A. She should be managed collaboratively with a specialty PH care center.
B. She should be referred to a local cardiology clinic.
C. She may be managed by her general practitioner as long as her right atrial pressure remains under 20 mmHg.
D. She should contact her insurance provider to determine her local coverage options.
Previous
←
Next
→
Enter your save and resume password
Cancel
Confirm